Cargando…
OR24-4 Targeting Hyperglucagonemia Reverses Glucagon Resistance
Elevation of glucagon levels and increase in alpha-cell mass are associated with states of hyperglycemia in diabetes. A better understanding of the molecular mechanisms governing glucagon secretion could have major implications in understanding abnormal responses to hypoglycemia in diabetic patients...
Autores principales: | Bernal-Mizrachi, Ernesto, Kramer, Nadejda Bozadjieva, Gittes, George, Lubaczeuski, Camila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624587/ http://dx.doi.org/10.1210/jendso/bvac150.732 |
Ejemplares similares
-
Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
por: Bozadjieva Kramer, Nadejda, et al.
Publicado: (2021) -
Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action
por: Lubaczeuski, Camila, et al.
Publicado: (2023) -
OR34-06 Gliclazide Restores Appropriate Glucagon Suppression During OGTT In MODY3 & MODY1 Patients: Results Of The “Glucagon In MODY” Study
por: Spiliotis, Ioannis Ilias, et al.
Publicado: (2023) -
OR31-4 Neonatal Vitamin D Deficiency and Insulin Resistance
por: McNerney, Kyle, et al.
Publicado: (2019) -
RF04 | PSUN233 Design of an Ultra-Stable Insulin/Glucagon Fusion Protein
por: Grabowski, Rachel, et al.
Publicado: (2022)